短期禁食对健康受试者全身CYP450介导药物代谢的影响:随机对照交叉试验
该随机对照交叉试验在12名健康受试者中采用CYP探针鸡尾酒(咖啡因、美托洛尔、咪达唑仑、奥美拉唑、华法林),比较隔夜禁食与36小时禁食后口服及静脉给药的血药浓度。结果显示短期禁食使咖啡因清除率增加17%、美托洛尔清除率增加13%、S-华法林清除率降低19%,但生物利用度无变化。
要点
- 短期禁食非均匀改变CYP介导的全身药物代谢。
- 咖啡因(CYP1A2)与美托洛尔(CYP2D6)清除率升高。
- S-华法林(CYP2C9)清除率降低,口服生物利用度不变。
核心结论
- 短期禁食以非均匀模式改变CYP介导的药物代谢,但不影响口服生物利用度。
研究设计与样本
- 随机对照交叉试验,12名健康受试者接受CYP探针鸡尾酒(咖啡因、美托洛尔、咪达唑仑、奥美拉唑、华法林)单次给药。
- 受试者在隔夜禁食(对照)和36小时禁食后分别进行口服和静脉给药,共四次。
- 药代动力学参数采用非线性混合效应模型软件NONMEM分析。
主要发现
- 短期禁食使全身咖啡因清除率增加17%(p=0.04)。
- 短期禁食使美托洛尔清除率增加13%(p<0.01)。
- 短期禁食使S-华法林清除率降低19%(p<0.01)。
- 禁食未影响生物利用度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Short-term fasting can alter drug exposure but it is unknown whether this is an effect of altered oral bioavailability and/or systemic clearance. Therefore, the aim of our study was to assess the effect of short-term fasting on oral bioavailability and systemic clearance of different drugs. METHODS: In a randomized, controlled, crossover trial, 12 healthy subjects received a single administration of a cytochrome P450 (CYP) probe cocktail, consisting of caffeine (CYP1A2), metoprolol (CYP2D6), midazolam (CYP3A4), omeprazole (CYP2C19) and warfarin (CYP2C9), on four occasions: an oral (1) and intravenous (2) administration after an overnight fast (control) and an oral (3) and intravenous (4) administration after 36 h of fasting. Pharmacokinetic parameters of the probe drugs were analyzed using the nonlinear mixed-effects modeling software NONMEM. RESULTS: Short-term fasting increased systemic caffeine clearance by 17% (p = 0.04) and metoprolol clearance by 13% (p < 0.01), whereas S-warfarin clearance decreased by 19% (p < 0.01). Fasting did not affect bioavailability. CONCLUSION: The study demonstrates that short-term fasting alters CYP-mediated drug metabolism in a non-uniform pattern without affecting oral bioavailability.
引用
- Lammers LA, Achterbergh R, van Schaik RHN, et al. Effect of Short-Term Fasting on Systemic Cytochrome P450-Mediated Drug Metabolism in Healthy Subjects: A Randomized, Controlled, Crossover Study Using a Cocktail Approach. Clin Pharmacokinet. 2017. PMID: 28229374. doi:10.1007/s40262-017-0515-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。